Cargando…
Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches
Candidemia and invasive candidiasis are the most common healthcare-associated invasive fungal infections, with a crude mortality rate of 25–50%. Candida albicans remains the most frequent etiology, followed by C. glabrata, C. parapsilosis and C. tropicalis. With the exception of a limited number of...
Autores principales: | Tortorano, Anna Maria, Prigitano, Anna, Morroni, Gianluca, Brescini, Lucia, Barchiesi, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702982/ https://www.ncbi.nlm.nih.gov/pubmed/34984009 http://dx.doi.org/10.2147/IDR.S274872 |
Ejemplares similares
-
Candidemia in Internal Medicine: Facing the New Challenge
por: Brescini, Lucia, et al.
Publicado: (2022) -
Antifungal Combinations in Dermatophytes
por: Brescini, Lucia, et al.
Publicado: (2021) -
Candidemia in intensive care units over nine years at a large Italian university hospital: Comparison with other wards
por: Mazzanti, Sara, et al.
Publicado: (2021) -
Antifungal Combinations against Candida Species: From Bench to Bedside
por: Fioriti, Simona, et al.
Publicado: (2022) -
In Vitro Activity of Novel Lipopeptides against Triazole-Resistant Aspergillus fumigatus
por: Fioriti, Simona, et al.
Publicado: (2022)